Michal Achmatowicz
About Michal Achmatowicz
Michal Achmatowicz is a Senior Principal Scientist at Mirati Therapeutics in San Diego, California, where he has worked since 2020. He holds a Master of Science in Chemistry from the University of Warsaw and a Ph.D. in Organic Chemistry from the Institute of Organic Chemistry, Polish Academy of Sciences.
Work at Mirati Therapeutics
Michal Achmatowicz has been serving as a Senior Principal Scientist at Mirati Therapeutics since 2020. In this role, he is involved in research and development efforts focused on advancing therapeutic solutions. His tenure at Mirati began after a brief period as a Principal Scientist within the same organization, where he worked for six months. The San Diego location serves as a hub for his scientific contributions.
Education and Expertise
Achmatowicz holds a Doctor of Philosophy (Ph.D.) in Organic Chemistry from the Institute of Organic Chemistry, Polish Academy of Sciences, where he studied from 1997 to 2001. He also earned a Master of Science (MS) in Chemistry from the University of Warsaw, completing his studies from 1993 to 1997. His educational background provides a strong foundation for his expertise in the field of chemistry and drug development.
Previous Experience at Amgen
Before joining Mirati Therapeutics, Michal Achmatowicz worked at Amgen for twelve years, from 2008 to 2020. He held the position of Senior Scientist during his final years at the company, contributing to various projects in the biotechnology sector. Prior to that role, he served as a Scientist at Amgen from 2003 to 2008, where he gained significant experience in scientific research and development.
Postdoctoral Research at Colorado State University
Achmatowicz completed a postdoctoral research associate position at Colorado State University from 2001 to 2003. This role allowed him to further develop his research skills and contribute to academic projects in the field of chemistry. His time at Colorado State University was an important step in his scientific career, bridging his education and subsequent industry roles.